IRIS
PREZIOSA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.001
AS - Asia 860
NA - Nord America 650
SA - Sud America 50
AF - Africa 16
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 637
CN - Cina 364
SE - Svezia 335
IT - Italia 277
SG - Singapore 208
HK - Hong Kong 172
RU - Federazione Russa 129
DE - Germania 94
FI - Finlandia 44
BR - Brasile 27
IN - India 27
NL - Olanda 23
TR - Turchia 23
IR - Iran 22
IE - Irlanda 19
BE - Belgio 13
AT - Austria 12
EG - Egitto 12
JP - Giappone 11
CA - Canada 10
FR - Francia 10
PT - Portogallo 10
AR - Argentina 8
ES - Italia 8
PL - Polonia 8
GB - Regno Unito 7
SA - Arabia Saudita 7
AU - Australia 6
PY - Paraguay 6
CL - Cile 5
NO - Norvegia 5
TW - Taiwan 5
CY - Cipro 4
KR - Corea 4
BD - Bangladesh 3
CO - Colombia 3
CZ - Repubblica Ceca 3
NG - Nigeria 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EU - Europa 2
KG - Kirghizistan 2
MX - Messico 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
DO - Repubblica Dominicana 1
HU - Ungheria 1
LB - Libano 1
PK - Pakistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.587
Salva come PNG Salva come JPEG
Città #
Shanghai 212
Hong Kong 163
Singapore 139
Princeton 97
Lawrence 96
Milan 89
Ashburn 88
Moscow 59
New York 48
Boardman 46
Helsinki 34
Rome 27
Cesano Boscone 24
Nuremberg 21
Dublin 18
Radebeul 15
Chennai 11
Los Angeles 11
Dallas 10
Shenzhen 10
Washington 10
Brussels 9
Lappeenranta 9
Ankara 8
Frankfurt am Main 8
Genoa 8
Istanbul 8
Guangzhou 7
Pisa 7
Romagnano Sesia 7
Siena 7
Tehran 7
Vienna 7
Beijing 6
Düsseldorf 6
Giza 6
Vänersborg 6
Wuxi 6
Ahmedabad 5
Amsterdam 5
Asunción 5
Cairo 5
Naples 5
Oslo 5
Seattle 5
Aversa 4
Catanzaro 4
Dresden 4
Krakow 4
Marostica 4
Munich 4
Philadelphia 4
Poznan 4
Rio Mayo 4
Riyadh 4
Tokyo 4
Toronto 4
Xi'an 4
Berlin 3
Bursa 3
Chongqing 3
Città di Castello 3
Dammam 3
Dongguan 3
Hanover 3
Lagos 3
Lisbon 3
Melbourne 3
Melsungen 3
Missaglia 3
Monza 3
New Taipei 3
Pittsburgh 3
Pune 3
Regina 3
Rio de Janeiro 3
Santiago 3
Scurzolengo 3
Stockholm 3
São Paulo 3
Tranemo 3
Wuhan 3
Abu Dhabi 2
Acton 2
Ancona 2
Baku 2
Barwāni 2
Bengaluru 2
Bishkek 2
Bogotá 2
Boston 2
Bussero 2
Calgary 2
Canterbury 2
Carmel 2
Castellammare di Stabia 2
Chandler 2
Chicago 2
Chillan 2
Chuo 2
Totale 1.545
Salva come PNG Salva come JPEG
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 156
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 76
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 66
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 44
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 43
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 41
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 37
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 36
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 35
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 34
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 32
Functional and structural MRI correlates of executive functions in multiple sclerosis 32
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 31
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 31
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 30
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 30
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 30
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 28
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 28
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 28
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 27
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 27
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 26
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 26
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 24
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective 24
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 24
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 24
Central vein sign and iron rim in multiple sclerosis: ready for clinical use? 24
Association between pathological and MRI findings in multiple sclerosis 24
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 23
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 23
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 22
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 22
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 22
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 22
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 22
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 22
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 21
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis 21
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 21
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 21
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 21
Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity 21
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 20
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 20
Information from ecological momentary assessments leads to over-medicalization: No 20
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study 20
Brain mapping in multiple sclerosis: Lessons learned about the human brain 20
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 20
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 20
Quantitative MRI adds to neuropsychiatric lupus diagnostics 20
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis 20
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 20
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 20
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression 20
Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study 20
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 19
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 19
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 19
The current role of MRI in differentiating multiple sclerosis from its imaging mimics 19
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study 19
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 19
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders 18
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 18
Brain reserve against physical disability progression over five years in multiple sclerosis 18
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study 18
Action observation training modifies brain gray matter structure in healthy adult individuals 18
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 18
Can post-mortem MRI be used as a proxy for in vivo? A case study 17
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 17
Human functional MRI 17
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 17
COVID-19 will change MS care forever – No 17
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience 17
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis? 17
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 17
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection 17
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 16
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 16
Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study 16
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 16
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 15
Identifying Progression in Multiple Sclerosis: New Perspectives 15
Measurement of white matter fiber-bundle cross-section in multiple sclerosis using diffusion-weighted imaging 15
Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study 15
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis 14
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 14
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 14
The role of DTI in multiple sclerosis and other demyelinating conditions 14
Il ruolo della risonanza magnetica nel monitoraggio clinico e della risposta terapeutica 14
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. 14
DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS 14
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study 14
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood 14
Functional and structural plasticity following action observation training in multiple sclerosis 14
Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment 14
Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional magnetic resonance imaging study 14
Clinically isolated syndromes suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes - a 2 year MR imaging study 14
Influence of cardiorespiratory fitness and MRI measures of neuroinflammation on hippocampal volume in multiple sclerosis 14
Totale 2.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.238
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 5 1 0 0
2020/202151 0 0 12 2 1 16 4 1 7 2 5 1
2021/2022130 1 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/20251.313 250 97 102 85 124 183 256 216 0 0 0 0
Totale 3.014